Repeat Head CT After Initial Negative Scan in Anticoagulated Patients
For neurologically intact adult patients on anticoagulants (including NOACs) or antiplatelet agents with a negative initial head CT after head trauma, routine repeat imaging is not recommended—discharge with clear return precautions is appropriate. 1, 2
Evidence-Based Recommendation Framework
For Patients with NEGATIVE Initial Head CT
Discharge without repeat imaging is safe when:
- Patient is neurologically intact at baseline examination 1, 2
- Initial head CT shows no hemorrhage 2
- Patient has adequate social support for home observation 2
The risk of delayed intracranial hemorrhage requiring intervention is extremely low (<1%) in this population. 1 Even when delayed hemorrhage occurs (0.5-1.5% of cases), it rarely necessitates neurosurgical intervention or results in death. 1, 3
Key supporting data:
- In 916 patients on NOACs with negative initial CT, only 14 (1.5%) developed delayed ICH on repeat scanning, and none required neurosurgical intervention or died 1
- A separate study of 420 patients on DOACs showed only 2 (0.5%) developed delayed ICH on routine 24-hour repeat CT, with neither requiring neurosurgical intervention 3
- The number needed to scan to identify one patient requiring intervention without neurologic decline is 305 4
Critical Exception: Elderly Patients on Aspirin
Consider brief observation (4-6 hours) or repeat imaging for patients ≥65 years on aspirin with high-risk features: 1, 2
- Loss of consciousness
- Post-traumatic amnesia
- GCS <15
One study found 4% delayed ICH rate in elderly patients on low-dose aspirin, with one requiring neurosurgical decompression and another death, suggesting greater caution in this specific subgroup. 1
For Patients with POSITIVE Initial Head CT
Routine repeat CT IS indicated when initial scan shows hemorrhage: 2, 5
- Obtain repeat CT at approximately 6 hours after symptom onset (captures window when most expansion occurs—26% within first hour, additional 12% by 20 hours) 5
- Obtain final CT at 24 hours to document final hematoma volume 5
- Anticoagulated patients have 3-fold increased risk of hemorrhage progression (26% vs 9%) 2, 5
Immediate Repeat CT Required For
Any neurological deterioration mandates immediate repeat CT regardless of timing: 2, 5
- Decreased GCS score
- New focal neurological deficit
- Worsening headache or vomiting
- Altered mental status
- Pupillary changes
Regarding Bismuth Subsalicylate Context
The salicylate component of bismuth subsalicylate can cause coagulopathy, particularly in patients with underlying liver disease. 6 However, this does not change the imaging algorithm—the decision for repeat CT is based on anticoagulation status, neurological examination, and initial CT findings, not the specific etiology of coagulopathy. 1, 2
Chronic bismuth subsalicylate use can cause salicylate toxicity presenting with confusion and falls 7, which could confound neurological assessment. If confusion is present at baseline from salicylate toxicity rather than intracranial pathology, this represents an abnormal neurological examination requiring admission for observation until normal exam is achieved. 2
Discharge Protocol for Negative Initial CT
Provide explicit return precautions for: 2
- Worsening headache
- Vomiting
- Confusion or difficulty waking
- Weakness or numbness
- Vision changes
- Seizures
Do NOT routinely withhold anticoagulation or antiplatelet medications after negative initial CT in neurologically intact patients, as thromboembolic risk may outweigh the small risk of delayed hemorrhage. 1, 2
Common Pitfalls to Avoid
- Performing unnecessary repeat imaging in stable patients with negative initial CT increases costs, radiation exposure, and does not change outcomes 2, 3, 4
- Failing to obtain initial CT in any anticoagulated patient with head trauma, even with minor mechanism 2
- Delaying repeat imaging when any neurological deterioration occurs 2, 5
- Discontinuing anticoagulation unnecessarily without considering thromboembolic risk 1, 2